JUN 05, 2019 12:00 PM PDT

Use of Functional Inhibitors of Acid Sphingomyelinase (FIASMA) to Treat Intracelluar Bacterial Infections

WRITTEN BY: Dena Aruta

Researchers at Virginia Commonwealth University presented the findings of their study published in Life Science Alliance that certain antidepressants may have the potential to treat infections with intracellular microorganisms. These drugs, known as functional inhibitors of acid sphingomyelinase (FIASMAs), interfere with acid sphingomyelinase (ASM), an enzyme that aids in the release of LDL cholesterol from the lysosome. The activity of ASM is an integral part of the infectious process with intracellular microorganisms because they target cholesterol within the cells. The FIASMAs analyzed in this study were desipramine, amitriptyline, and nortriptyline, which belong to the drug class, tricyclic antidepressants.

"Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases," Carlyon said.

Anaplasma phagocytophilum, Coxiella burnetii, Chlamydia trachomatis, and Chlamydia pneumoniae were used to demonstrate that the activity of ASM is a vital part of the infectious process. The four organisms are "obligate intracellular vacuole-adapted bacterial pathogens that target host cholesterol trafficking pathways" and are responsible for the diseases human granulocytic anaplasmosis, Q fever, pneumonia, and a sexually transmitted infection. 

The findings of the study demonstrated that ASM inhibition was more effective with desipramine when testing  A.phagocytophilum and C. burnetii than the other two organisms. Desipramine was less effective with C. pneumoniae since it uses sources of both LDL cholesterol and non-LDL cholesterol during its growth cycle. C. trachomatis showed even less inhibition than C. pneumoniae. 

"It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated," Carlyon said. "These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetii."

Carlyon went on to state that: "What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria," Carlyon said. "I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body."

The researchers suggest that, since these drugs are likely to prevent resistance, they should be evaluated clinically as an alternative to antibiotics or in conjunction with one to augment their efficacy. 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
DEC 29, 2020
Cardiology
Does Physical Activity Help Reduce the Risk of Aneurysms?
DEC 29, 2020
Does Physical Activity Help Reduce the Risk of Aneurysms?
An active lifestyle is a proven way to prevent many types of cardiovascular diseases. The increased blood flow can preve ...
JAN 01, 2021
Cardiology
Blood Vessel Damage Caused by COVID-19 Disrupts Brain
JAN 01, 2021
Blood Vessel Damage Caused by COVID-19 Disrupts Brain
Scientists have been trying to determine if the SARS-CoV-2 virus infects brain cells directly, or if the virus severely ...
JAN 13, 2021
Plants & Animals
San Diego Zoo's Gorillas Positive for COVID-19
JAN 13, 2021
San Diego Zoo's Gorillas Positive for COVID-19
Earlier this week, the Associated Press reported that several gorillas at the San Diego Zoo Safari Park tested positive ...
JAN 26, 2021
Immunology
Can we Stop Multiple Sclerosis Progression?!
JAN 26, 2021
Can we Stop Multiple Sclerosis Progression?!
Multiple sclerosis is known for its progression of symptoms even after a period of complete remission. There is no way o ...
JAN 21, 2021
Health & Medicine
Injectable Cannabis Overdose Drug Being Developed
JAN 21, 2021
Injectable Cannabis Overdose Drug Being Developed
It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and ...
JAN 24, 2021
Neuroscience
Is Parkinson's Disease Linked to Gut Fungi?
JAN 24, 2021
Is Parkinson's Disease Linked to Gut Fungi?
Studies show an association between the gut microbiome and Parkinson's disease. Up until now, though, no studies had ...
Loading Comments...